Hairy cell leukemia cells are relatively NK-insensitive targets

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Interferon alpha (IFN alpha) is used to treat hairy cell leukemia (HCL).
• The mechanism of IFN alpha's efficacy in HCL is not fully understood.
• Natural killer (NK) cells are crucial in innate immunity against cancer cells.

Purpose of the Study:

• To investigate if IFN alpha enhances NK cell-mediated lysis of HCL cells.
• To determine the susceptibility of HCL cells to various immune cell-mediated cytolysis.

Main Methods:

• Hairy cell leukemia cells were co-cultured with peripheral blood mononuclear cells (PBMCs) from healthy donors.
• PBMCs were activated with IFN alpha.
• Susceptibility to lysis was measured by 51Cr release.
• Cold target inhibition assays were used to assess NK cell recognition.

Main Results:

• Hairy cells showed significant resistance to lysis by both fresh and IFN alpha-activated PBMCs.
• A minor level of lysis observed was NK cell-mediated (T cell receptor independent).
• Hairy cells were insensitive to lymphokine-activated killer (LAK) cells but sensitive to antibody and complement-mediated lysis.
• Cold target inhibition confirmed a lack of NK cell recognition of hairy cells.

Conclusions:

• IFN alpha does not enhance NK cell-mediated killing of hairy cells.
• Hairy cells are generally resistant to NK cell-mediated cytolysis due to poor target recognition.
• Alternative mechanisms may explain the therapeutic effects of IFN alpha in HCL.